Commonwealth of Pennsylvania Public School Employees Retirement System’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
Other funds holding ABCL
BBA
O
ACH
Commonwealth of Pennsylvania Public School Employees Retirement System's ABCL Position: Q1 2025 in Review
Commonwealth of Pennsylvania Public School Employees Retirement System sold out of AbCellera Biologics (ABCL) in Q1 2025, closing a stake of 21,664 shares — an estimated $63.5K sold.
Commonwealth of Pennsylvania Public School Employees Retirement System first reported a position in ABCL in Q4 2022 and held it in 8 quarters. The position peaked at $2.54M in Q4 2022. 129 funds tracked by Wall St. Rank hold ABCL as of Q1 2025.
- Commonwealth of Pennsylvania Public School Employees Retirement System reported no remaining AbCellera Biologics position as of Q1 2025 after selling out during the quarter.
- Commonwealth of Pennsylvania Public School Employees Retirement System sold 21,664 AbCellera Biologics shares in Q1 2025, an estimated $63.5K.
- Commonwealth of Pennsylvania Public School Employees Retirement System first reported a position in AbCellera Biologics in Q4 2022 and held it in 8 quarters.
- Commonwealth of Pennsylvania Public School Employees Retirement System's AbCellera Biologics position peaked at $2.54M in Q4 2022.
- 129 funds tracked by Wall St. Rank held AbCellera Biologics as of Q1 2025.
Based on Commonwealth of Pennsylvania Public School Employees Retirement System's 13F filing for Q1 2025, filed 13 May 2025.